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Background: Genetically modiﬁed organisms (GMOs) have numerous biomedical, agricultural and en-
vironmental applications. Development of accurate methods for the detection of GMOs is a prerequisite
for the identiﬁcation and control of authorized and unauthorized release of these engineered organisms
into the environment and into the food chain. Current detection methods are unable to detect un-
characterized GMOs, since either the DNA sequence of the transgene or the amino acid sequence of the
protein must be known for DNA-based or immunological-based detection, respectively.
Methods: Here we describe the application of an epigenetics-based approach for the detection of
mammalian GMOs via analysis of chromatin structural changes occurring in the host nucleus upon the
insertion of foreign or endogenous DNA.
Results: Immunological methods combined with DNA next generation sequencing enabled direct inter-
rogation of chromatin structure and identiﬁcation of insertions of various size foreign (human or viral)
DNA sequences, DNA sequences often used as genome modiﬁcation tools (e.g. viral sequences, trans-
poson elements), or endogenous DNA sequences into the nuclear genome of a model animal organism.
Conclusions: The results provide a proof-of-concept that epigenetic approaches can be used to detect the
insertion of endogenous and exogenous sequences into the genome of higher organisms where the
method of genetic modiﬁcation, the sequence of inserted DNA, and the exact genomic insertion site
(s) are unknown.
General signiﬁcance: Measurement of chromatin dynamics as a sensor for detection of genomic ma-
nipulation and, more broadly, organism exposure to environmental or other factors affecting the epi-
genomic landscape are discussed.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Recombinant DNA technology allows the modiﬁcation of par-
ticular characteristics of animals, plants, or microbes by introdu-
cing selected segments of genetic material from other, sometimes
non-related, organisms. According to the World Health Organiza-
tion, genetically modiﬁed organisms (GMOs) are deﬁned as or-
ganisms in which the DNA has been altered in a way that does not
occur naturally by mating and/or natural recombination [24]. Ge-
netically engineered animals represent a pioneering technology
with various applications in biomedicine, through the production
of various proteins, drugs, vaccines, and tissues for human use; in
agriculture, through the generation of more efﬁcient and disease-B.V. This is an open access article u
s).
.resistant livestock; and in diet, through enhancement of the
quality and reduction in the cost of food production [25]. Given
these beneﬁts of GMOs, it is necessary to develop accurate and
sensitive methods to detect, track, and assess the authorized and
unauthorized release of GMOs into the environment and into the
food chain [7,19]. Additionally, the development of such detection
methods is a prerequisite for reliable identiﬁcation and control of
engineered organisms that create risks to the food supply and to
human health (e.g. agroterrorism).
Commonly used methods cannot detect uncharacterized ge-
netically engineered organisms, since either the DNA sequence of
the transgene or the amino acid sequence of the protein must be
available for DNA- (e.g. PCR, probe magnetic capture/spectroscopy,
microarrays) or immunochemical- (i.e. monoclonal and polyclonal
antibodies) based detection, respectively [15,17,18,2,22,28,5,9].
Similarly, designing DNA microarrays for GMO surveillance would
be challenging given the extreme diversity of genomic sequences
among organisms and the great variety of molecular tools that cannder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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We propose that insertion of DNA sequences into a host gen-
ome causes remodeling of the chromatin structure by altering the
interactions between histone proteins and DNA sequences around
the inserted elements. Such chromatin structure changes could
inﬂuence gene expression by modifying both short- and long-
range regulatory interactions, therefore leading to alterations in
protein expression, and eventually to a desired physiological out-
come. To this end, we applied genome-wide chromatin im-
munoprecipitation coupled with high-throughput sequencing
(ChIP-seq) technology to characterize DNA–histone interactions
for the identiﬁcation of molecular signatures corresponding to
insertion of endogenous or exogenous DNA elements into the
mouse genome. The results provide a proof of concept that chro-
matin mapping technologies can be used to detect the insertion of
DNA sequences into the genome of a higher mammalian organism.2. Materials and methods
2.1. Sample selection
Muscle tissue samples from wild-type and genetically modiﬁed
mice (Jackson Laboratory, Bar Harbor, ME, USA) were of FVB/NJ
genetic background, were all male, and were 8 weeks old. Wild-
type (stock# 001800) and three GMO samples were selected for
testing. Genome alterations present in the GMO mouse samples
included insertions of various size endogenous (mouse) or foreign
(e.g. human, viral) DNA elements that were incorporated into the
host genome using various genome modiﬁcation tools (e.g. viral
sequences, transposons) and engineering methods (e.g. embryonic
stem cells transformation or pronuclear injection). A list of the
samples used in this study along with their genomic modiﬁcations
and size of DNA insertion is shown in Table 1. The composition of
transgenic insertions is illustrated in Fig. 1.
GMO sample 1 (stock# 018304; [4]) was created via the mi-
croinjection method and contained an inserted transgene holding
the human alpha-skeletal actin (ACTA1) promoter sequence, the
full-length human tropomyosin-3 cDNA sequence (TPM3) and a
cassette containing the simian virus 40 (SV40) small t-antigen
(tAg) intron and 3′UTR (Fig. 1A). GMO sample 2 (stock# 012460;
[6]) was created via the microinjection method and contained an
insertion of 40 copies of a DNA sequence cassette consisting of the
entire coding region of the mouse GTP-binding proteins class Gq
protein subunit Gaq (Gnaq) gene, under control of a mouse alpha-
myosin heavy chain (Myh6) promoter, followed by a SV40 intronTable 1
Wild-type and genetically modiﬁed organism (GMO) mice samples used in this study.
Sample Genetic
background
Gender Age Engineering approach
Wild-type (n¼4) FVB/NJ Male 8 wks N/A
GMO sample 1
(#018304)
FVB/NJ Male 8 wks Microinjection
GMO sample 2
(#012460)
FVB/NJ Male 8 wks Microinjection
GMO sample 3
(#017594)
FVB/NJ Male 8 wks Sleeping Beauty
transposonand a polyadenylation signal (polyA) (Fig. 1B). GMO sample 3
(stock# 017594; [32]) was created via co-injection of two trans-
genes using the Sleeping Beauty (SB) transposon approach. The
ﬁrst transgene contains a left and right inverted repeat/direct re-
peat sequence (IR/DR) known as the SB transposon recognition
site, a mouse tyrosinase (Tyro) enhancer sequence, and Tyro
minigene (TyBS). The second transgene has the mouse protamine 1
(Prm1) promoter, a 25 bp linker, SB10 gene, and a rabbit β-globin
splice/polyA sequence (Fig. 1C).
2.2. Chromatin immunoprecipitation (ChIP-seq)
ChIP-seq experiments were performed in agreement with the
guidelines set forth by the ENCODE project [14]. Three histone
antibodies were used for the chromatin immunoprecipitation ex-
periment, speciﬁcally: H3K4me3 (Millipore, MA) which binds to
active promoters, H3K36me3 (AbCam, MA) which binds to active
exon boundaries, and H3K4me1 (AbCam, MA) which binds to ac-
tive enhancers [11]. An optimized protocol for isolation of nuclei
from skeletal muscle tissue was developed and was based on a
previously published method [26]. Brieﬂy, minced skeletal muscle
was cross-linked with formaldehyde and nuclei were prepared for
chromatin immunoprecipitation according to the chromatin
shearing (sonication) method described by [21]. Chromatin sam-
ples were incubated with each histone antibody and im-
munoprecipitated using Protein A/G Magnetic Beads (Thermo
Fisher Scientiﬁc, MA) according to the product speciﬁcations.
Samples were reverse cross-linked and puriﬁed using a PCR Pur-
iﬁcation Kit (Qiagen, MD), followed by quantiﬁcation using the
Quant-iT PicoGreen dsDNA Assay Kit (Life Technologies, CA). The
DNA fragment size range was determined using the Bioanalyzer
High Sensitivity ChIP (Agilent Technologies, CA).
Validation of the DNA–histone immunoprecipitation reactions
was conducted by quantitative PCR using SYBR FAST qPCR Master
Mix (KAPA Biosystems, MA) and positive control primers (IDT, IA)
designed to bind speciﬁc genomic regions known to be im-
munoprecipitated by the three tested antibodies. Speciﬁcally,
ampliﬁcation of the following gene regions was veriﬁed before
sequencing was initiated: Actg1 and Actb for H3K4me3, Actg1 and
Elf1 for H3K36me3, and Actg1, Elf1, and Gapdh for H3K4me1.
Samples were prepared for multiplex sequencing following the
Illumina ChIP-seq Library Prep Kit (Illumina, CA). Sequencing li-
braries were quantiﬁed with Quant-iT PicoGreen dsDNA Assay Kit
(Life Technologies, CA) and Illumina/Universal Quantiﬁcation Kit
(KAPA Biosystems, MA), and DNA fragment sizes were determined
using the Bioanalyzer High Sensitivity ChIP (Agilent Technologies,Endogenous (mouse)
insertions
Exogenous (human, viral,
etc.) insertions
Total insertion size
(kb)
N/A N/A N/A
N/A Human ACTA1 promoter 40
Human TPM3 cDNA
SV40 tAg Intron & 3′UTR
Mouse Myh6 promoter SV40 Intron & poly(A) 200
Mouse Gnaq cDNA
Transgene A: Transgene A: 8
Mouse Tyro enhancer Left and right IR/DR
Mouse Tyro minigene
Transgene B: Transgene B: 2
Mouse Prm1 promoter Linker
SB10 gene
Rabbit β-globin splice/poly
(A)
Human ACTA1
promoter Human TPM3 cDNA
SV40 tAg Intron
& 3’UTR
Mouse Tyro
enhancer
Mouse Tyro 
minigene
Right 
IR/DR
Left 
IR/DR
Transgene A
Linker SB10 gene Rabbit β-globin splice/poly(A)
Mouse Prm1
promoter
Transgene B
Mouse Myh6
promoter Mouse Gnaq cDNA
SV40 intron 
& poly(A)
Downstream 
Insertions
Upstream 
Insertions
Coding 
Insertions
Fig. 1. GMO transgenic insertions. Illustration of inserted cassettes for the three GMO samples tested in this study. (A) GMO sample 1 contains a 40 kb insertion containing
the human ACTA1 promoter and human TPM3 cDNA sequence with a downstream viral SV40 element. (B) GMO sample 2 contains a cassette with the mouse Myh6 promoter
and mouse Gnaq cDNA sequence followed by a viral 3′ UTR element. (C) GMO sample 3 consists of two transgenes inserted at different genomic locations. Transgene A
contains a left and right inverted repeat/direct repeat sequence (IR/DR), a mouse Tyrosine (Tyro) enhancer, and Tyro minigene; transgene B contains the mouse protamine 1
(Prm1) promoter, linker, SB10 gene, and a rabbit 3′UTR.
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and sequencing was performed on the Genome Analyzer IIx
(Illumina, CA), generating 35 bp single end reads (Fig. 2a).
2.3. Genomic annotations
Mouse genomic annotations including chromosome, coding strand,
and exon boundaries were downloaded from the UCSC RefSeq Genes
table using the following settings: Assembly: July 2007, NCBI37/mm9;
Group: Gene and Gene Predictions; Track: RefSeq Genes; Table: re-
fGene; and Region: Genome. The entire human ACTA1 genomic region
72.5 kb (hg19; chr1; 229564492–229572343) and full length TPM3
cDNA sequence (NM_152263) were obtained from Genbank and used
as reference sequences during alignment. Four SV40 intronic regions
were identiﬁed at the following positions relative to the SV40 Viral
Genome (Genbank NC_001669): pos: 295–434 (late 19s intron), pos:
527–1462 (late 16s intron), pos: 4572–4917 (large TAg intron), and
pos: 4572–4636 (small tAg intron).
2.4. Data processing: insertion of endogenous mouse sequences
Data workﬂow was performed following guidelines outlined by
[14] (Fig. 2b). ChIP-seq data was demultiplexed using CASAVA 1.8.2
(Illumina, CA) and high quality sequencing data was retained after a
per-lane and per-sample data quality check. High quality data was
deﬁned as that with a mean quality score of at least 35. For
mouse endogenous DNA insertions, the standalone ELAND2(Illumina, CA) aligner was used for mapping the high quality de-
multiplexed sequence reads to the mouse genome (mm9). The
quality of the alignment was assessed by examining the number of
uniquely mapped reads (i.e. those reads that align to a single genomic
location). For the three antibodies used (H3K4me3, H3K36me3, and
H3K4me1), wild-type mice samples averaged 12.271.5 M,
12.671.3 M, and 12.472.2 M uniquely mapped reads, respec-
tively. GMO sample 1 generated 17.7 M, 17.0 M, and 9.1 M;
GMO sample 2 generated 8.2 M, 6.9 M, and 9.0 M; and GMO
sample 3 generated 15.0 M, 18.4 M, and 17.1 M, uniquely
mapped reads, for the three antibodies, respectively.
ChIP-seq peak ﬁnding was performed with Model-based Ana-
lysis for ChIP-seq (MACS 1.4.2) using the built-in mouse genome-
size setting [27]. The total number of called peaks across the
mouse genome for the four wild-type samples averaged
21,56172007 reads for H3K4me3, 58,74173310 reads for
H3K36me3, and 74,98879,157 reads for H3K4me1. The total
number of peaks for GMO sample 1 was 24,647, 56,205, and 72,727
peaks; for GMO sample 2 was 11,420, 66,991, and 76,019 peaks;
and for GMO sample 3 were 24,648, 50,402, and 88,566 peaks for
the H3K4me3, H3K36me3, and H3K4me1 histone antibodies, re-
spectively. Peaks were examined and graphically represented
using MATLAB (R2013b). For each chromosomal region of interest,
peak data for all three of the histone antibodies were plotted on a
single graph, for each wild-type and each GMO sample. These peak
plots were qualitatively examined to identify both similarities and
differences between wild-type and GMO samples.
Sample Selection
8 wk old, male, FVB/NJ
Wild-type (n = 4), GMO (n = 3)
Antibody Selection
H3K4me3 (promoters)
H3K36me3 (exons)
H3K4me1 (enhancers)
Chromatin Immunoprecipitation
Isolate skeletal 
muscle
Mince muscle, crosslink 
& sheer chromatin
Incubate chromatin 
& antibodies
Immuno-
precipitate
Reverse crosslink, 
purify & quantify
Sequencing
Sequencing Library 
Preparation
Quantification & Fragment 
Size Determination
Cluster 
Generation
35 bp single-end 
sequencing
Data Pre-Processing
Demultiplex
Sequencing reads
Align reads to Reference 
Mouse Genome
Alignment 
QC Check 
Sequence 
QC Check
Endogenous Mouse Sequences
Identify 
Peaks
Generate Read 
Density Plots
Exogenous Mouse Sequences
Align unmapped reads 
to Custom Library
Identify 
Peaks
Generate Read 
Density Plots
Mapped Reads Unmapped Reads
Fig. 2. Laboratory and ChIP-seq data analysis ﬂow diagram. ChIP-seq was performed on wild-type and genetically modiﬁed (GMO) mouse samples with three open
chromatin histone binding antibodies. Single end sequencing was performed on the Illumina GAIIx and reads demultiplexed with CASAVA. High quality reads were mapped
to the mouse reference genome (mm9) and peaks identiﬁed with MACS. Unmapped mm9 reads were remapped to a custom reference library and peaks identiﬁed with
MACS.
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The GMO samples used in this research effort each contained
an inserted transgene holding some exogenous, non-mouse,
genomic sequences; speciﬁcally, the human ACTA1 gene region,
the human TPM3 cDNA sequence, the four SV40 intronic regions,
and the SB10 cassette (Table 1, Fig. 1). Accordingly, high quality
ChIP-seq reads that had failed to align to the mouse reference
genome (i.e. unmapped reads) were aligned to a custom reference
genomic library containing these exogenous genomic sequences
(Fig. 2b). Sequence Alignment/Map tools (SAMtools 0.1.18; [16])
were used to generate FASTQ ﬁles for the unaligned reads, which
were then aligned to the aforementioned reference library using
the ELAND2 standalone aligner. Peak ﬁnding was executed on the
resulting BAM ﬁles using MACS 1.4.2 to generate WIG ﬁles with
the genome-size setting modiﬁed to represent the size of the re-
ference used for alignment. The resulting peak data was then
further examined and graphically represented MATLAB (R2013b).3. Results
3.1. Detection of transgene insertions carrying endogenous mouse
sequences
The chromatin structure of genetically engineered mouse sam-
ples was assessed for the detection of changes caused by the
insertion of transgenic DNA sequences into the host genome. Thesestudies employed ChIP-seq methodology for high resolution, gen-
ome-wide mapping of DNA fragments associated with selected
proteins followed by comparison of those maps between genetically
matched transgenic and wild-type mice samples. The ChIP-seq
process was initiated with induction of cross-linking between DNA
and its associated proteins. Chromatin was then isolated, subjected
to sonication for DNA fragmentation, and sheared chromatin was
immunoprecipitated using antibodies against speciﬁc histones,
speciﬁcally H3K4me3, H3K4me1, and H3K36me3. H3K4me3 is a
hallmark of actively transcribed protein-coding promoters in eu-
karyotes; H3K4me1 marks active transcriptional enhancers; and
H3K36me3, has been associated with the exons of actively tran-
scribed genes [11]. Immunoprecipitated DNA samples were pur-
iﬁed, ligated to sequencing adapters, and assayed using the Next
Generation Genome Analyzer IIx sequencing platform (Illumina,
CA). This step generated short sequence reads of the DNA fragments
bound by the protein(s) of interest.
Initially, transgenic samples carrying native mouse elements
were examined. Although the genomic location of the transgene
was unknown, alignment of ChIP-seq data to the endogenous
mouse genomic locations was expected. Speciﬁcally, an increase in
the number of reads mapped to these known genomic locations
should appear similar to a copy number variation (CNV) event. The
native genomic positions for the mouse Myh6 promoter and Gnaq
coding sequence transfected into GMO sample 2 (#012460) and
the Tyro enhancer sequence, TyBS minigene, and Prm1 promoter
transfected into GMO sample 3 (#017594) were investigated. The
transgene injected into GMO sample 1 did not contain any
Wild-type Sample 1 GMO Sample 1 GMO Sample 2 GMO Sample 3
Wild-type Sample 1 GMO Sample 1 GMO Sample 2 GMO Sample 3
Wild-type Sample 1 GMO Sample 1 GMO Sample 2 GMO Sample 3
Wild-type Sample 1 GMO Sample 1 GMO Sample 2 GMO Sample 3
H3K4me3 Ab H3K36me3 Ab H3K4me1 Ab Gene
Fig. 3. Endogenous mouse peak plots. Peak read density plots for controls and test samples at various endogenous genomic positions. (A) Myh6 promoter region in
chromosome 14 shows increased signal for GMO sample 2. (B) Exons 4 and 5 in Gnaq gene show no distinct variation for any sample tested; (C) Tyro minigene and Tyro
enhancer region show increased signal for GMO sample 3; and (D) Protamine promoter region shows increased signal for sample 3.
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ACTA1 Regulatory Element
Wild-type Sample 1 GMO Sample 1 GMO Sample 2 GMO Sample 3
Wild-type Sample 1 GMO Sample 1 GMO Sample 2 GMO Sample 3
SV40 Introns SV40tAG
Wild-type Sample 1 GMO Sample 1 GMO Sample 2 GMO Sample 3
Wild-type Sample 1 GMO Sample 1 GMO Sample 2 GMO Sample 3
HR
HR
H3K4me3 Ab H3K36me3 Ab H3K4me1 Ab
Fig. 4. Exogeneous mouse peak plots. Read density plots for the mouse unmapped sequencing reads. (A) A number of sequencing reads aligned to the human ACTA1 gene in
only the GMO sample 1. The gray vertical bans indicate regions of homology between the human and mouse genomes. (B) Sequencing reads aligned to the human TPM3 gene
in only the GMO sample 1 data. The gray vertical bans indicate regions of homology between the human and mouse genomes. (C) Unmapped reads aligning to the SV40
genomic reference template in GMO sample 1 data. (D) Reads aligning to the SB10 cassette within GMO sample 3 data are shown in relation to the absence of sequencing
read alignment with any other sample. (For interpretation of the references to color in this ﬁgure, the reader is referred to the web version of this article.)
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for GMO sample 1 were evaluated at this stage. Qualitative ex-
amination of peaks at the endogenous mouse genomic regions for
one representative wild-type sample and the three GMO mice is
shown in Fig. 3. The four mouse endogenous genomic regions for
the Myh6 (Fig. 3A), Gnaq (Fig. 3B), Tyr and TyBS (chr7 separated by
12 kb) (Fig. 3C), and Prm1 (Fig. 3D) genes are shown. A very
broad set of peaks at the Myh6 region for all three antibodies
tested can be seen when comparing GMO sample 2 to the wild-
type and other GMO samples (Fig. 3A). In contrast, GMO sample
2 showed a decrease in the number of peaks for the H3K36me3
antibody as well as a modest reduction in the number of peaks for
the other two antibodies surrounding exons 4 and 5 of the Gnaq
gene (Fig. 3B). This may indicate an inactivation of the chromatin
region surrounding both the endogenous and exogenous Gnaq
sites therefore causing poor representation in the Chip-seq data.
GMO sample 3 contains three native mouse gene sequences: the
Tyr enhancer and TyBS minigene (Fig. 3C) and the Prm1 promoter
(Fig. 3D). These regions show an increase in the amount of reads
for the H3K4me1 and H3K36me3 antibodies when compared to
the wild-type and other GMO samples.
3.2. Detection of transgene insertions carrying exogenous mouse
sequences
Next, we examined transgenic samples containing the insertion
of elements foreign to the mouse genome. Since these sequences
are not native to the mouse genome, the associated ChIP-seq reads
were not expected to align to the mouse reference genome. These
unmapped reads were thus realigned to a new reference sequence
collection corresponding to the exogenous inserted sequence
(Section 2). If these reads align to this custom reference sequence,
then the presence of the sequence has been identiﬁed in the
sample of interest.
All three of the test samples for the study contained insertions
foreign to the mouse genome (Table 1). The foreign insertions
originated from the human genome (ACTA1 and TPM3 in GMO
sample 1), a viral genome (SV40 in GMO samples 1 and 2), and a
common genetic engineering transfection tool (SB10 cassette in
GMO sample 3). The unmapped reads were aligned to a reference
genome, the detected peaks were plotted, and qualitatively ex-
amined for similarities and differences between wild-type and
GMO samples (Fig. 4).
3.2.1. Insertion of human sequences into the mouse genome
As shown in Table 1, the foreign elements in GMO sample
1 were two human insertions (ACTA1 promoter and TPM3 cDNA) as
well as the Simian Virus small tAg (SV40). The sequence for the
entire Human ACTA1 gene was used as the reference genome to
align the unmapped reads (see Section 2). Fig. 4A illustrates the
detected peaks for a single wild-type sample and the three GMO
samples. As shown, GMO sample 1 contains a strong peak differ-
ence when compared to the other samples for all three antibodies
tested for the ACTA1 gene. This peak mapped to one of the known
ACTA1 regulatory elements (light blue vertical lines) conﬁrming
the insertion of an ACTA1 promoter into GMO sample 1. For the
wild-type controls and the two GMO samples not containing these
insertions (i.e. GMO samples 2 and 3), only minor peaks (o50
reads) were observed. Further examination revealed that these
peaks aligned to the homologous regions of the ACTA1 gene (i.e.
those regions of high sequence similarity between the mouse and
human genomes) which are denoted by the gray bands in Fig. 4.
The sequence for the entire human TPM3 gene was also used as
a reference template for unmapped read mapping. GMO sample
1 contained a large peak located at the 5′ end of the TPM3 gene
which is absent for all other samples (Fig. 4B). Similar to theresults for the human ACTA1 gene, minor background peaks (o50
reads) for all three tested antibodies were observed for all other
samples.
3.2.2. Insertion of viral sequences into the mouse genome
The entire SV40 sequence was used as the reference genome to
investigate the insertion of the SV40 small tAg present in GMO
sample 1 and SV40 intron present in GMO sample 2. As shown in
Fig. 4C, GMO sample 1 showed two separate locations of peaks,
one spanning a region centered around 2.7 kb and another
centered around 4.4 kb, where each location had a peak for each
antibody tested. The region at 4.4 kb is adjacent to the small tAg,
the inserted element. The area around 2.7 kb is in a region that
exhibits sequence similarity to the mouse genome and most likely
represents either an artifact of the alignment or an additional SV40
sequence present in the transgene but not originally annotated. In
contrast to the peaks identiﬁed in GMO sample 1, the other two
GMOs and all four wild-type samples had no peaks aligning to the
SV40 genome. It is not unexpected that GMO sample 2 failed to
have peaks aligning to SV40 even though it contained an intron of
the SV40 genome since the histone antibodies used in these ex-
periments are not known to bind to intronic regions.
3.2.3. Insertion of transposase gene elements into the mouse genome
As shown in Table 1 and in Fig. 1, the exogenous inserted ele-
ment in GMO sample 3 was the Sleeping Beauty (SB) cassette. This
cassette contains multiple sequence components (e.g. IR/DR, SB10,
linker), which were concatenated to form a complete reference
sequence of the transgene for alignment of the unmapped reads.
As expected, the wild-type and GMO samples 1 and 2 had no
peaks aligned to the SB10 cassette sequence. GMO sample 3, which
contained the SB10 insertion, showed a response for all antibodies
tested across the reference sequence (Fig. 4D). It should be noted
that the alignment to the SB10 cassette sequence was executed in
two different ways. First, as previously described, the elements of
the cassette were concatenated to form a single reference se-
quence used for alignment. Second, the alignment was done using
each SB10 cassette element as its own reference sequence. The
peaks detected were the same regardless if the alignment was
done to the synthesized sequence or each component separately.4. Discussion
It has been established that the dynamics of chromatin struc-
ture are modulated by epigenetic factors, such as DNA methylation
and histone modiﬁcations (acetylation, methylation and ubiqui-
tylation), nucleoprotein remodeling complexes, and tissue-speciﬁc
proteins [10]. Histone modiﬁcations in particular, affect chromatin
structure and subsequent gene expression through local changes
of nucleosome structure and recruitment of chromatin remodeling
complexes [23]. We postulated that insertion of DNA sequences
into a host eukaryotic organism may alter the patterns of inter-
action of nuclear DNA with a variety of proteins, such as histones,
transcription factors and other regulatory, DNA-associated trans-
factors. These differences would result from: a) direct interactions
between the inserted DNA sequences and nuclear proteins, b)
changes in the chromatin structure owing to transcriptional acti-
vation of the inserted gene(s), and c) DNA methylation changes
that may in turn affect DNA–protein association patterns. How-
ever, to our knowledge, there has been neither comprehensive
characterization of the effects on chromatin structure of the in-
sertion of DNA sequences into the mammalian genome nor ex-
ploitation of such effects for GMO detection. The objective of the
present study was therefore to test the hypothesis that chromatin
mapping methods can be used to detect the footprint of DNA
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method of modiﬁcation used, the exact sequence of the inserted
DNA or its insertion position in the host genome.
In this work, immunological methods combined with DNA next
generation sequencing enabled direct interrogation of chromatin
structure and identiﬁcation of genetic modiﬁcations into the nu-
clear genome of a model animal organism. These studies used
publicly available muscle tissue samples from genetically modiﬁed
mice generated viamultiple DNA insertion methods and carrying a
variety of sequence alterations. These alterations included inser-
tions of various size foreign (human or viral) DNA sequences, DNA
sequences often used as genome modiﬁcation tools (e.g. viral se-
quences, transposon elements), or endogenous DNA sequences
resulting in gene duplications or CNVs in the host genome. To
minimize the intrinsic chromatin structure variability between
animals, all mice used in this study were of the same genetic
background (FVB/NJ), were all male, and were approximately
8 weeks of age. Muscle tissue control and engineered mice were
subjected to ChIP-seq, a technique that enriches DNA fragments to
which a speciﬁc protein is bound, and enables genome-wide
proﬁling of protein–DNA interactions and identiﬁcation of poten-
tial differences between transgenic and wild-type organisms. For
this study, we employed antibodies against posttranslationally
modiﬁed histone molecules known to associate with different
active chromatin regions; H3K4me3, which marks active pro-
moters, H3K4me1 that binds to active enhancers, and H3K36me3,
which marks exons of actively transcribed genes [11]. Presumably,
depending on the appropriate selection of antibodies against dif-
ferent DNA binding proteins, a similar approach can be used to
detect inserted genes that are either in an active (transcribed) or
inactive (silenced) state at the time of harvesting, depending on
the type of tissue source and/or gene temporal expression pattern.
Such antibodies associated with transcribed or silenced parts of
the genome have been demonstrated and validated previously
[29,30,31,11].
The insertion of an endogenous sequence into the host genome,
irrespective of where in the genome it has been inserted, would
result in increased copies of that sequence, which upon alignment
of the ChIP-seq data is expected to appear as a change in the en-
richment level in the endogenous location of that element. For
example, Fig. 3A illustrates this scenario in the case of insertion of
mouse Myh6 promoter sequences, depicting an increased signal
response. Interestingly, this response was not limited to only
H3K4me3, which marks active promoters but also to H3K4me1
and H3K36me3, which mark active enhancers and exons of ac-
tively transcribed genes, respectively. This result is in agreement
with a proposed model of enhancer activity and long-distance
gene activation [3]. Additionally, there are reports showing en-
hancers can be marked by histone H3K4me3 [1], further sug-
gesting physical interactions between H3K4me3-marked pro-
moters and H3K4me1-marked enhancers. Signatures of DNA in-
sertions were also detected in the case of insertion of multiple
endogenous transgenes at different locations of a mouse genome.
A sample carrying insertion of endogenous sequences containing
the Tyrosinase enhancer and Tyrosinase minigene exhibited in-
creased response with the H3K4me1 and H3K36me3 antibodies
(Fig. 3C), which as described above, mark active enhancers and
exons of actively transcribed genes, respectively.
A different approach was taken for analysis of ChIP-seq data
originating from samples isolated from animals containing inser-
tion of elements foreign to the host genome, such as human and
viral sequences or sequences of commonly used genetic en-
gineering tools (e.g. the SB10 cassette). Since such ChIP-seq reads
did not align to the mouse genome, they were tested for alignment
to a collection of reference sequences to assess the potential pre-
sence of a foreign sequence into the mouse genome. A signalresponse for the presence of human ACTA1 and TPM3 gene inser-
tions was detected with all three antibodies tested (Fig. 4A and B,
respectively). Similarly, all three antibodies tested showed a signal
for the presence of SV40 viral sequences in the expected sample
(Fig. 4C). Interestingly, a sample containing an intron of the SV40
genome had no peak reads align to the viral sequence (Fig. 4C),
which may be explained by the fact that the antibodies used for
this study are known to correspond to active exons, enhancers or
promoters, but not intronic regions of the genome. Using the
aforementioned approach, we were also able to identify the pre-
sence of engineered SB10 transposase elements; alignment of
pulled-down sequences to a compiled reference sequence led to
successful allocation of the signals generated by any of the three
antibodies tested to only the particular sample that had been
modiﬁed with these sequences (Fig. 4D).
It is envisioned that a similar approach can be followed for
identiﬁcation of GMOs created through modiﬁcations by foreign
DNA sequences based on an automated screening of ChIP se-
quences against a library of reference data consisting of sequences
derived from published genetic engineering tools as well as gen-
omes from multiple organisms different than the host leveraging
available reference ﬁles (e.g., NCBI). For compound insertions, as
shownwith the example of the SB10 cassette, it is sufﬁcient for the
library to contain the building blocks of the cassette independently
of each other. Advances in de novo assembly of very short reads (e.
g., [13] could be explored to enable assembly of unaligned reads to
agnostically identify exogenous inserts. This approach would
render the need for a custom reference sequences library obsolete
but may require additional analysis upon sequence assembly as
well as potential modiﬁcations to the experimental parameters
(e.g., increase read lengths or paired-end reads).
These studies successfully determined signatures in the ChIP-
Seq data for both endogenous and exogenous insertions as a result
of the modiﬁcations. Our approach of initially aligning to the host
genome followed by an analysis of the unaligned reads is re-
commended when examining an unknown sample suspected of
having a modiﬁcation. Analyzing these results requires knowledge
of the expected variability relative to the host genome as well as
the statistics of unmapped reads for unmodiﬁed organisms. Hence,
one of the greatest challenges toward a practical application of the
approach outlined in this study is the intrinsic variation in chro-
matin states between samples. It is evident that the cellular
chromatin structure depends on the underlying genetic back-
ground and is constantly changing in response to physiological
and environmental factors, playing an integral role in regulation of
gene expression and phenotype. In addition, the algorithms de-
veloped here will need to be extended to further normalize
chromatin structure data and generate baseline epigenetic pat-
terns accounting for variations in the genetic background, age, and
environmental factors affecting chromosome dynamics. Con-
tinuation of the extraordinary progress in performance and cost of
high resolution/high-throughput sequencing of large genomes,
array technologies, single-cell level characterization platforms, and
software data analysis tools achieved in the recent years [20], in
combination with the vast amount of information being generated
from the human and model organism Encyclopedia of DNA Ele-
ments (ENCODE) projects, should allow chromatin proﬁling across
numerous tissues, cell types, and conditions. Furthermore, appli-
cation of an integrative systems biology approach using data
originating from ChIP-seq combined with other genome-wide in-
terrogation platforms (methylation arrays, gene expression and
proteomic data, etc.) in concert with Bayesian statistics could
allow separation of the effect on chromatin structure originating
from genomic modiﬁcations from that caused due to population
epigenetic variability and stochastic/environmental effects. Such
approach may also capture secondary effects of endogenous
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regions through long range chromatin interactions and/or activa-
tion of metabolic pathways related to the inserted elements. Im-
portantly, a well-deﬁned, probabilistic model of chromatin struc-
ture should have applications beyond GMO detection, allowing
comprehensive mapping of the structural and functional elements
in the genome and enabling characterization of their changes in
response to a variety of internal or external stimuli. These stimuli
may include various environmental and/or physiological factors,
exposure to which may cause a long-lasting signature on chro-
matin and DNA structure.
The described approach represents a general methodology for
detection and subsequent sequencing of inserted DNA elements
into a host genome introduced by conventional or emerging gene
editing tools, such as the CRISPR (clustered regularly interspaced
short palindromic repeats)/Cas9 (CRISPR-associated protein 9)
system, Zinc ﬁnger nucleases (ZNFs), or transcription activator-like
effector nucleases (TALENs). Although the proposed epigenetics
approach is not suitable to pinpoint the use of genetic engineering
tools that do not result in incorporation of their DNA sequences
into the host genome, it may allow detection of chromatin pattern
changes that result from collateral genome alterations caused by
those technologies (e.g., CRISPR/Cas9), such as off-target double
stranded breaks and insertion or deletion mutations (indels). In
addition, analysis of chromatin structure may shed light on how
the epigenetic environment might affect the frequency of such off-
target events.
An alternative approach for the detection of GMOs could in-
volve whole genome sequencing as a direct method for inter-
rogation of inserted elements. However, current technologies for
whole genome sequencing require long read lengths, resulting in
high reagent cost per sample. In addition, coverage requirements
in whole genome sequencing limit the number of samples that can
be multiplexed in a single sequencing run. Furthermore, the large
quantity of data generated by whole genome sequencing increases
the required processing resources, complexity and required time
for analysis. The need for higher read length, sequence coverage,
sample size limitations and volume of data would make this ap-
proach less efﬁcient with respect to cost, speed and ease of ana-
lysis than the proposed epigenetics-based methodology described
in this work. In this study, by focusing on epigenetic marks, we
limit the amount of sequencing data required to detect a GMO,
considerably reducing the cost of these endeavors. Moreover, the
proposed approach provides additional information with respect
to the chromatin structure and its activity status resulting from the
inserted elements.
Overall, this study provides proof-of-concept for the applica-
tion of genome-wide interrogation methods for detection of epi-
genetic signatures of genetic manipulation. Effective detection of
GMOs should enable control and security of adversely genetically
manipulated organisms and detection of infectious agents (e.g.
prion, viruses) genetically engineered into zoonotic species, af-
fecting the food chain. It should be noted that the ﬁndings of this
work should have broader applications not only for GMO detection
but also for improving transgene expression. Although transgenic
technology holds great promise for advancing our basic under-
standing of gene expression and regulation as well as practical
applications, including production of pharmaceutical proteins and
food quality improvement, such efforts are generally hampered
due to the fact that transgenes expression is unpredictable and
often much lower than anticipated [12]. Transgene expression is
associated with regulatory elements and their epigenetic mod-
iﬁcations upon transformation. Better understanding of chromatin
biology and remodeling upon gene transfer should enable pre-
diction of gene expression and more efﬁcient production of
transgenic animals for biomedical and agricultural applications.5. Conclusion
This study provides a proof-of-concept that epigenetic ap-
proaches can be used to detect the insertion of endogenous and
exogenous sequences into the genome of higher organisms where
the method of genetic modiﬁcation, the sequence of inserted DNA,
and the exact genomic insertion site(s) are unknown. In a broader
sense, characterizing chromatin dynamics can be applied beyond
genomic manipulation to include organism exposure to environ-
mental or other factors affecting the epigenomic landscape.Acknowledgments
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